Interaction of Beclin 1 with survivin regulates sensitivity of human glioma cells to TRAIL-induced apoptosis

FEBS Letters

Volumn 584, Issue 16, 2010, Pages 3519-3524

  Niu, Ting Kuang ^a   Cheng, Yan ^a   Ren, Xingcong ^a   Yang, Jin Ming ^a  

^a PENN STATE CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Autophagy; Beclin 1; Survivin; Tumor necrosis factor related apoptosis inducing ligand

Indexed keywords

BECLIN 1; SURVIVIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; DOWN REGULATION; GENE SILENCING; GLIOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; SENSITIZATION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BASE SEQUENCE; CELL LINE, TUMOR; DNA PRIMERS; DOWN-REGULATION; GENE KNOCKDOWN TECHNIQUES; GLIOMA; HUMANS; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; PROTEIN INTERACTION MAPPING; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 77955663516     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.07.018     Document Type: Article

References (17)

1. LaCasse E.C., Mahoney D.J., Cheung H.H., Plenchette S., Baird S., Korneluk R.G. IAP-targeted therapies for cancer. Oncogene 2008, 27:6252-6275.
2. Altieri D.C. Survivin, cancer networks and pathway-directed drug discovery. Nat. Rev. Cancer 2008, 8:61-70.
3. Ulasov I.V., Tyler M.A., Zhu Z.B., Han Y., He T.C., Lesniak M.S. Oncolytic adenoviral vectors which employ the survivin promoter induce glioma oncolysis via a process of beclin-dependent autophagy. Int. J. Oncol. 2009, 34:729-742.
4. Liang C., Feng P., Ku B., Dotan I., Canaani D., Oh B.H., Jung J.U. Autophagic and tumour suppressor activity of a novel Beclin 1-binding protein UVRAG. Nat. Cell Biol. 2006, 8:688-699.
5. Boya P., Kroemer G. Beclin 1: a BH3-only protein that fails to induce apoptosis. Oncogene 2009, 28:2125-2127.
6. Erlich S., et al. Differential interactions between Beclin 1 and Bcl-2 family members. Autophagy 2007, 3:561-568.
7. Pattingre S., et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005, 122:927-939.
8. Guha M., Plescia J., Leav I., Li J., Languino L.R., Altieri D.C. Endogenous tumor suppression mediated by PTEN involves survivin gene silencing. Cancer Res. 2009, 69:4954-4958.
9. Hoffman W.H., Biade S., Zilfou J.T., Chen J., Murphy M. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J. Biol. Chem. 2002, 277:3247-3257.
10. Zhao J., Tenev T., Martins L.M., Downward J., Lemoine N.R. The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner. J. Cell Sci. 2000, 113(Pt 23):4363-4371.
11. Siegelin M.D., Reuss D.E., Habel A., Herold-Mende C., von Deimling A. The flavonoid kaempferol sensitizes human glioma cells to TRAIL-mediated apoptosis by proteasomal degradation of survivin. Mol. Cancer Ther. 2008, 7:3566-3574.
12. Brown J.M., Attardi L.D. The role of apoptosis in cancer development and treatment response. Nat. Rev. Cancer 2005, 5:231-237.
13. Deveraux Q.L., Reed J.C. IAP family proteins-suppressors of apoptosis. Genes Dev. 1999, 13:239-252.
14. Wang R., Lin F., Wang X., Gao P., Dong K., Zou A.M., Cheng S.Y., Wei S.H., Zhang H.Z. Silencing livin gene expression to inhibit proliferation and enhance chemosensitivity in human cells. Cancer Gene Ther. 2008, 15:402-412.
15. Panner A., James C.D., Berger M.S., Pieper R.O. MTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells. Mol. Cell. Biol. 2005, 25:8809-8823.
16. Fulda S., Wick W., Weller M., Debatin K.M. Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat. Med. 2002, 8:808-815.
17. Han J., Hou W., Goldstein L.A., Lu C., Stolz D.B., Yin X.M., Rabinowich H. Involvement of protective autophagy in TRAIL resistance of apoptosis-defective tumor cells. J. Biol. Chem. 2008, 283:19665-19677.